Literature DB >> 21830

Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage.

F W Green, M M Kaplan, L E Curtis, P H Levine.   

Abstract

In a series of in vitro studies, both the soluble (plasmatic) coagulation system and the cellular (platelet-mediated) aspect of coagulation were shown to be extremely sensitive to relatively minor increases in hydrogen ion concentration. All studies became abnormal at pH 6.8. At pH 6.4, assays of the intrinsic and extrinsic coaglution systems, the polymerization of fibrinogen, and assay of the availability of platelet phospholipid (platelet factor 3) were twice prolonged over control values. Platelet aggregation was reduced by more than 50%. At pH 5.4 in vitro, platelet aggregation and plasma coagulation were both virtually abolished. Furthermore, previously formed platelet aggregates disaggregated at a slightly acid pH. Pepsin further enhanced platelet disaggregation. Because gastric acidity is normally two to four orders of magnitude greater than that which abolishes platelet aggregation and plasma clotting in vitro, and pepsin is present in abundance, we call attention to the probable antihemostatic effect of hydrocloric acid and pepsin in the upper gastrointestinal tract. This in vitro study may provide a rationale for meticulous regulation of intragastric pH in an effort to control upper gastrointestinal hemorrhage.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 21830

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  105 in total

Review 1.  Intravenous omeprazole after endoscopic treatment of bleeding peptic ulcers.

Authors:  K R Palmer
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

2.  Optimal duration of proton pump inhibitor for healing artificial ulcers after endoscopic submucosal dissection for early gastric cancer.

Authors:  Takuji Gotoda
Journal:  Dig Dis Sci       Date:  2011-12-25       Impact factor: 3.199

3.  Early effects of oral administration of omeprazole and roxatidine on intragastric pH.

Authors:  Hiroshi Iida; Shingo Kato; Yusuke Sekino; Eiji Sakai; Takashi Uchiyama; Hiroki Endo; Kunihiro Hosono; Yasunari Sakamoto; Koji Fujita; Masato Yoneda; Tomoko Koide; Hirokazu Takahashi; Chikako Tokoro; Ayumu Goto; Yasunobu Abe; Noritoshi Kobayashi; Kensuke Kubota; Eiji Gotoh; Shin Maeda; Atsushi Nakajima; Masahiko Inamori
Journal:  J Zhejiang Univ Sci B       Date:  2012-01       Impact factor: 3.066

4.  High-dose vs low-dose proton pump inhibitors for upper gastrointestinal bleeding: a meta-analysis.

Authors:  Liu-Cheng Wu; Yun-Fei Cao; Jia-Hao Huang; Cun Liao; Feng Gao
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

5.  Distinctive aspects of peptic ulcer disease, Dieulafoy's lesion, and Mallory-Weiss syndrome in patients with advanced alcoholic liver disease or cirrhosis.

Authors:  Borko Nojkov; Mitchell S Cappell
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

6.  Pharmacological Treatment in Upper Gastrointestinal Bleeding.

Authors:  Kelvin L Y Lam; John C T Wong; James Y W Lau
Journal:  Curr Treat Options Gastroenterol       Date:  2015-12

7.  Population pharmacokinetics of intravenous pantoprazole in paediatric intensive care patients.

Authors:  Géraldine Pettersen; Mohamad-Samer Mouksassi; Yves Théorêt; Line Labbé; Christophe Faure; Bao Nguyen; Catherine Litalien
Journal:  Br J Clin Pharmacol       Date:  2008-10-23       Impact factor: 4.335

Review 8.  Upper endoscopy in patients with acute myocardial infarction and upper gastrointestinal bleeding: results of a decision analysis.

Authors:  Patrick Yachimski; Chin Hur
Journal:  Dig Dis Sci       Date:  2008-07-26       Impact factor: 3.199

Review 9.  Gastric acid inhibition in the treatment of peptic ulcer hemorrhage.

Authors:  Kevin A Ghassemi; Thomas O G Kovacs; Dennis M Jensen
Journal:  Curr Gastroenterol Rep       Date:  2009-12

10.  Cimetidine therapy does not prevent rebleeding from peptic ulceration.

Authors:  D L Carr-Locke; D Taverner; A C Wicks
Journal:  Postgrad Med J       Date:  1984-06       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.